Cytodyn Inc (CYDY)

[3X Charm]

C-20, Look at the raw numbers, not the weighted numbers ( I do not believe this methodology will hold sway with the FDA) and see if you think the changes in symptoms, that are self reported, are significant enough to move the needle for the FDA. I am seriously not trying to bash. I do not know about drug trials, but I do work with data and statistics and explain them as an expert witness. 18 tables were not filed in 8K , so you are relying on NP. Look on your own at the data in the tables with out NPs arbitrary weighting for degree of symptoms and do a gut check on the info as compared to placebo. I didn’t believe when many were predicting failure for CD 12, but it failed. I do believe LH was not successful based on the slides I reviewed. We will see if history repeats. I wish you luck. I still hold some shares but see this dripping below $1 when LH trial rejected and BLA is delayed again.